Efficacy of Proprioceptive Neuromuscular Facilitation in Pain Relief (PNF)

March 13, 2018 updated by: DÉBORA WANDERLEY VILLELA, Universidade Federal de Pernambuco

Efficacy of Proprioceptive Neuromuscular Facilitation in Pain Relief in Women With Migraine

The purpose of this study is to determine whether the contract-relax technique of proprioceptive neuromuscular facilitation, and the static stretching exercise are effective in reducing the frequency, intensity and duration of headache and in improving the perception of quality of life in women with migraine.

Study Overview

Status

Completed

Conditions

Detailed Description

This is an randomized clinical trial, double blind, comparing two interventions in women with migraine, whose diagnosis was confirmed by a neurologist.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pernambuco
      • Recife, Pernambuco, Brazil, 50740-560
        • Departamento de Fisioterapia da Universidade Federal de Pernambuco

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Age between 18and 40 years
  • Clinical diagnosis of migraine
  • Participants with at least one day with acute migraine per month, with attacks lasting 4-72 hours.

Exclusion Criteria:

  • Obesity type I, II or III, according to the classification of Body Mass Index.
  • Pregnancy, lactation or both.
  • Presence of meningitis, demyelinating diseases, cerebral aneurysm, intracranial hypertension, myopathies, myelopathy, fibromyalgia, symptomatic neck disc herniation, rheumatoid arthritis and history of tumors in the brain or spine.
  • Participants who performed other manual therapeutic interventions or other physical therapy modalities in the head or neck during the survey period.
  • Participants who have daily prophylactic medication for migraine.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PNF contract-relax
Proprioceptive neuromuscular facilitation, using the technique of contract-relax on neck diagonal.
Proprioceptive neuromuscular facilitation, using the technique of contract-relax on neck diagonal.
Experimental: Static stretching
Static stretching of neck muscles.
Static stretching of neck muscles.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain change
Time Frame: "Change from Baseline Pain at 8th - 10th week"; "Change from Baseline Pain at 12th - 14th week"
"Daily headache"
"Change from Baseline Pain at 8th - 10th week"; "Change from Baseline Pain at 12th - 14th week"
The global perception of change
Time Frame: "global perception of change at 12th - 14th week"
"Patient Global Impression of Change Scale"
"global perception of change at 12th - 14th week"
Feasibility for successful random allocation
Time Frame: "12 months"
"successful random allocation of 30 patients during a 12-months period"
"12 months"
Proportion of eligible patients randomly assigned for each group (target ≥70%)
Time Frame: "12 months"
"the proportion of eligible patients randomly assigned for each group (target ≥70%)"
"12 months"
Proportion of eligible patients who completed 30-day follow-up (target ≥95%)
Time Frame: "12 months"
"the proportion of randomly assigned patients who completed 30-day follow-up after the end of the treatment (target ≥95%)"
"12 months"

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Medicine intake in migraine attacks
Time Frame: "Change from Baseline Medicine intake at 8th - 10th week"; "Change from Baseline Medicine intake at 12th - 14th week"
"Daily headache"
"Change from Baseline Medicine intake at 8th - 10th week"; "Change from Baseline Medicine intake at 12th - 14th week"
Change in Adverse effects of the intervention
Time Frame: "Change from Baseline adverse effects at 8th - 10th week"; "Change from Baseline adverse effects at 12th - 14th week"
Daily headache
"Change from Baseline adverse effects at 8th - 10th week"; "Change from Baseline adverse effects at 12th - 14th week"
Change in Neck mobility
Time Frame: "Change from Baseline neck mobility at 8th - 10th week"; "Change from Baseline neck mobility at 12th - 14th week"
Goniometer "Cervical Range of Motion (CROM)"
"Change from Baseline neck mobility at 8th - 10th week"; "Change from Baseline neck mobility at 12th - 14th week"
Change in pressure pain threshold
Time Frame: "Change from Baseline pressure pain threshold at 8th - 10th week"; "Change from Baseline pressure pain threshold at 12th - 14th week"
"Computerized Algometer"
"Change from Baseline pressure pain threshold at 8th - 10th week"; "Change from Baseline pressure pain threshold at 12th - 14th week"
Change in neck disability index
Time Frame: "Change from Baseline neck disability index at 8th - 10th week"; "Change from Baseline neck disability index at 12th - 14th week"
Questionnaire "Neck disability index"
"Change from Baseline neck disability index at 8th - 10th week"; "Change from Baseline neck disability index at 12th - 14th week"
Change in severity of migraine-related disability
Time Frame: "Change from Baseline Migraine disability assessment at 8th - 10th week"; "Change from Baseline Migraine disability assessment at 12th - 14th week"
Questionnaire "Migraine disability assessment"
"Change from Baseline Migraine disability assessment at 8th - 10th week"; "Change from Baseline Migraine disability assessment at 12th - 14th week"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: DÉBORA W VILLELA, MASTER, Universidade Federal de Pernambuco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2016

Primary Completion (Actual)

August 1, 2017

Study Completion (Actual)

August 1, 2017

Study Registration Dates

First Submitted

September 10, 2015

First Submitted That Met QC Criteria

September 14, 2015

First Posted (Estimate)

September 15, 2015

Study Record Updates

Last Update Posted (Actual)

March 15, 2018

Last Update Submitted That Met QC Criteria

March 13, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Migraine Disorders

Clinical Trials on PNF contract-relax

3
Subscribe